You can now enjoy the slide deck from this session, which took place at the 2013 SharpBrains Virtual Summit (September 19–20th).
How can innovators leverage crowdfunding and strategic investments to gain distribution reach? With distribution as a common bottleneck to the sustainable commercialization of innovation, value-added capital is often critical to enable steady progress in the translation of brain science from lab to life. This is especially true in non-medical areas, which lack appropriate infrastructure to commercialize and distribute innovative solutions. What can innovators learn from Discovery’s investment in Lumosity, AAA’s partnership with Posit Science, and Emotiv’s Kickstarter crowdfunding campaign?
- Chair: Matthew Bishop, US Business Editor and New York Bureau Chief of The Economist
- Dan Fox, Senior VP Corporate Development at Discovery Communications
- Jeff Zimman, Chairman of Posit Science
- Tan Le, CEO of Emotiv Lifesciences